More about

Type 2 Diabetes

News
August 24, 2021
2 min read
Save

HbA1c decrease larger with insulin pen vs. syringes for older adults with type 2 diabetes

HbA1c decrease larger with insulin pen vs. syringes for older adults with type 2 diabetes

Older adults with type 2 diabetes in Brazil using an insulin pen had a lower HbA1c after 24 weeks than those using syringes, according to findings published in Diabetology & Metabolic Syndrome.

News
August 23, 2021
1 min read
Save

Non-invasive FibroTest diagnoses stage of fibrosis, NASH grade in type 2 diabetes

The Nash-FibroTest non-invasive panel successfully diagnosed the stage of fibrosis as well as graded nonalcoholic steatohepatitis and steatosis among patients with type 2 diabetes, according to a recent study.

News
August 23, 2021
3 min read
Save

Does intergenerational transmission of obesity begin in the womb or home?

Does intergenerational transmission of obesity begin in the womb or home?

Fetal and infant environments do not cause type 2 diabetes or obesity. Instead, these environments make type 2 diabetes and obesity much more likely because they change the sensitivity of the individual to the obesogenic and metabolic milieu after birth.

News
August 11, 2021
2 min read
Save

Once-weekly semaglutide lowers HbA1c, body weight after 1 year in real-world data

Once-weekly semaglutide lowers HbA1c, body weight after 1 year in real-world data

Adults with type 2 diabetes had reductions in both body weight and HbA1c after 1 year on semaglutide similar to the reductions observed in clinical studies, according to data from a real-world study published in Diabetic Medicine.

News
July 29, 2021
2 min read
Save

Many women with gestational diabetes do not receive type 2 diabetes screening after birth

Many women with gestational diabetes do not receive type 2 diabetes screening after birth

Women in the United Kingdom who had gestational diabetes were not often screened for type 2 diabetes in accordance with national guidelines, a recent analysis showed.

News
July 29, 2021
2 min read
Save

TODAY: Youth-onset type 2 diabetes precedes high burden of early adulthood complications

TODAY: Youth-onset type 2 diabetes precedes high burden of early adulthood complications

Long-term follow-up of a cohort of children and adolescents diagnosed with type 2 diabetes showed most developed complications, including microvascular disease, in early adulthood that progressed steadily over time.

News
July 23, 2021
2 min read
Save

FDA approves once-weekly exenatide for children with type 2 diabetes

FDA approves once-weekly exenatide for children with type 2 diabetes

The FDA approved the GLP-1 receptor agonist exenatide for children aged 10 to 17 years with type 2 diabetes, the first once-weekly injectable approved for pediatric use in the United States, according to an industry press release.

News
July 09, 2021
1 min read
Save

FDA approves finerenone to reduce CV, renal events in patients with CKD, type 2 diabetes

FDA approves finerenone to reduce CV, renal events in patients with CKD, type 2 diabetes

The FDA approved Kerendia for reducing the risk for kidney and heart complications among adults with chronic kidney disease associated with type 2 diabetes.

News
July 09, 2021
1 min read
Save

FDA approves Kerendia for the treatment of CKD, type 2 diabetes

FDA approves Kerendia for the treatment of CKD, type 2 diabetes

The FDA approved Kerendia for reducing the risk for kidney and heart complications among adults with chronic kidney disease associated with type 2 diabetes.

News
July 09, 2021
2 min read
Save

Once-weekly exenatide safe, effective for youths with type 2 diabetes

Once-weekly exenatide safe, effective for youths with type 2 diabetes

Adolescents with type 2 diabetes were more likely to achieve HbA1c targets after 24 weeks of once-weekly exenatide compared with placebo, with trends observed toward decreased fasting plasma glucose and reduced body weight, data show.

View more